文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

将肝病学与酒精使用障碍住院患者的成瘾护理相结合可减少未来与肝脏相关的事件。

Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.

作者信息

George Paul, Marshall Chantelle, Zhang Wei, Goodman Russell, Butler Michael, Patel Suraj J, Mitchell Mack, Schaefer Esperance, Luther Jay

机构信息

Department of Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

MGH Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Hepatol Commun. 2025 Jul 29;9(8). doi: 10.1097/HC9.0000000000000780. eCollection 2025 Aug 1.


DOI:10.1097/HC9.0000000000000780
PMID:40719548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12306700/
Abstract

BACKGROUND: Strategies to identify patients with early alcohol-associated liver disease (ALD), prior to the development of liver-related decompensated events, and promote alcohol therapy engagement in these patients are urgently needed to stem the rising tide of mortality associated with ALD. METHODS: We compared the rate of incident liver-related decompensating events in hospitalized patients with alcohol use disorder (AUD) seen either by an integrated hepatology and addiction care approach or addiction care alone at 2 academic medical centers. Cox proportional hazards regression model and a Kaplan-Meier analysis were used. FINDINGS: An integrated approach of hepatology and addiction care is associated with a reduced likelihood of future liver-related decompensating events in hospitalized patients with AUD. This finding correlated with an increased uptake of medical alcohol therapy and a reduced likelihood of an alcohol-associated readmission. Integrated hepatology and addiction care for hospitalized AUD patients may help reduce the progression of ALD.

摘要

背景:迫切需要采取策略来识别早期酒精性肝病(ALD)患者,即在肝脏相关失代偿事件发生之前,并促使这些患者参与酒精治疗,以阻止与ALD相关的死亡率上升趋势。 方法:我们比较了在2个学术医疗中心,采用肝病与成瘾综合治疗方法或仅采用成瘾治疗方法治疗的酒精使用障碍(AUD)住院患者中,肝脏相关失代偿事件的发生率。使用了Cox比例风险回归模型和Kaplan-Meier分析。 研究结果:肝病与成瘾综合治疗方法与AUD住院患者未来发生肝脏相关失代偿事件的可能性降低有关。这一发现与药物酒精治疗的接受度增加以及酒精相关再入院的可能性降低相关。对AUD住院患者进行肝病与成瘾综合治疗可能有助于减少ALD的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70f2/12306700/e00b4a7ecbf2/hc9-9-e0780-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70f2/12306700/e00b4a7ecbf2/hc9-9-e0780-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70f2/12306700/e00b4a7ecbf2/hc9-9-e0780-g001.jpg

相似文献

[1]
Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.

Hepatol Commun. 2025-7-29

[2]
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease.

J Addict Med. 2025

[3]
Concomitant treatment of alcohol associated liver disease and alcohol use disorder in the nontransplant setting: A scoping review.

Alcohol Clin Exp Res (Hoboken). 2025-8

[4]
Early detection of liver disease in patients with alcohol use disorder improves long-term abstinence.

Alcohol Alcohol. 2024-9-21

[5]
Treatment of alcohol use disorder in alcohol-associated liver disease: A meta-analysis.

Hepatol Commun. 2025-4-30

[6]
Burden, Trends, and Projections of Alcohol-Associated Liver Disease and Alcohol Use Disorder in the Asia-Pacific Region 1990-2040.

Liver Int. 2025-8

[7]
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.

Cochrane Database Syst Rev. 2016-4-4

[8]
A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse.

Clin Transplant. 2024-7

[9]
Proactive case finding of alcohol-related liver disease in high-risk populations: A systematic review.

Liver Int. 2024-6

[10]
Baclofen for alcohol use disorder.

Cochrane Database Syst Rev. 2023-1-13

本文引用的文献

[1]
The impact of integrated care on clinical outcomes in patients with alcohol-associated liver disease: Early outcomes from a multidisciplinary clinic.

Hepatol Commun. 2025-2-10

[2]
Integrated hepatology and addiction care for inpatients with alcohol use disorder improves outcomes: a prospective study.

Hepatol Commun. 2023-5-1

[3]
Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.

JAMA Netw Open. 2022-5-2

[4]
Creation of an Inpatient Alcohol Liver Service Improves Early Liver Disease Detection in Patients With Alcohol Use Disorder.

Clin Gastroenterol Hepatol. 2023-6

[5]
Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic.

J Subst Abuse Treat. 2021-11

[6]
Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study.

Lancet Public Health. 2020-6

[7]
Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.

Clin Gastroenterol Hepatol. 2019-1-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索